Obadi M. Obadi

Emergency Medicine

5716 Cleveland St Ste 200
Virginia Beach, VA 23462

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2 publications

Does the Addition of Subcutaneous Basal Insulin Administration Safely Improve Outcomes of Diabetic Ketoacidosis Compared With Intravenous Insulin Infusion Alone?

Does the Addition of Subcutaneous Basal Insulin Administration Safely Improve Outcomes of Diabetic Ketoacidosis Compared With Intravenous Insulin Infusion Alone?

Journal: Annals of emergency medicine

Published: January 05, 2026

A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas.

A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas.

Journal: Blood

Published: July 29, 2021

Showing 1-2 of 2

Last Updated: 09/26/2026